Behind the Headlines: Key Takeawys From Intuitive Surgical, Inc.'s Earnings

Intuitive Surgical released earnings last week, and investors who were hoping to get a bit more clarity on this stock from the report were sadly disappointed. The company declined to give 2014 guidance given the changing industry dynamics, including the impact of Obamacare. Shares fell 6% on the news.

Although investors didn't get specific guidance from the company, they did get a chance to see some idea of what to expect this year. Sales of the company's da Vinci surgical systems and the procedure growth rate are expected to be lower than in 2013. Combining that with an expected upward trend in operating expenses as the company focuses on international growth in Europe and Japan, and 2014 starts to look potentially challenging for the stock.

In this video from Friday's Market Checkup, Motley Fool health-care analyst David Williamson takes investors through the key things to watch with Intuitive Surgical, to see if it can pull out of the doldrums ahead.

How is Obamacare affecting your investments?
Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." This free guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.

The article Behind the Headlines: Key Takeawys From Intuitive Surgical, Inc.'s Earnings originally appeared on

David Williamson has no position in any stocks mentioned. Follow David on Twitter: @MotleyDavid.The Motley Fool recommends and owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story